Strong Momentum: Saint Bella Group Issues Interim Positive Profit Alert, with Adjusted Net Profit Expected to Rise by Over 54% 
GMG Announces Updated Battery Brand 
White Gold Corp. Announces Positive Preliminary Economic Assessment with C$1.9 Billion After-Tax NPV, 38% IRR and 1.7 Year Payback Period on the White Gold Project, Yukon, Canada 
Unitree Robotics (688836.SH) Opens for Subscription Today: Shoucheng, Meituan and Other Early Investors Poised for Significant Gains as Core Investor Valuations Re-rate 
Guotai Haitong Proposes Privatisation of Guotai Junan International to Accelerate Overseas Strategic Integration Orion aims to achieve carbon neutrality by 2030
ORION CORPORATION PRESS RELEASE 27 APRIL 2021 at 9.00 a.m. EEST Orion aims to achieve…
Biophytis – Convening of Another Combined General Meeting at a Later Date
PARIS and CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Biophytis SA (Euronext Growth Paris:…
Tiziana Life Sciences to participate in a Fireside Chat on 28 April 2021 at 10:30 a.m. EDT
NEW YORK and LONDON, April 27, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ:…
Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease
Ensifentrine improves lung function and quality of life when added to maintenance tiotropium LONDON and…
Novozymes delivers solid Q1 results with 3% organic sales growth and strong earnings
Novozymes delivered 3% organic sales growth in the first quarter of the 2021 financial year…
Interim report for Q1 2021
Please see the full report in PDF format Attachment 2021_21_Q12021_CompanyAnnouncement
U.S. Patent Office Issues Notice of Allowance for Nicox’s Latanoprostene Bunod in Normal Tension Glaucoma
Press Release U.S. Patent Office Issues Notice of Allowance for Nicox’s Latanoprostene Bunod in Normal…
ObsEva Initiates PRIMROSE 3 Bone Mineral Density Follow-Up Study in PRIMROSE 1 and PRIMROSE 2 Trial Participants
–Long-term follow-up study to evaluate bone mineral density in women completing at least 20 weeks…
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
NEWS RELEASE – REGULATED INFORMATION 27 April 2021, 7:00 a.m. CET IRVINE, CA, and HERSTAL,…
Sequana Medical Announces Annual and Extraordinary General Meetings of Shareholders on 27 May 2021
Publication of Annual Report 2020 GHENT, Belgium, April 27, 2021 (GLOBE NEWSWIRE) — Sequana Medical…
Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed.
Q1 net sales declined -2% (cc¹, +1% USD), due to prior year COVID-19 related forward…
Reata Announces FDA Accepted for Filing the NDA for Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome
Approximately 30,000-60,000 Patients in the United States Are Affected With Alport Syndrome, a Life-Threatening Disease With…
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS). Dear…
Travere Therapeutics to Report First Quarter 2021 Financial Results
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
MediWound to Report First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 5, 2021
YAVNE, Israel, April 26, 2021 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully integrated…
PDS Biotechnology Announces Conference Call and Webcast for First Quarter Financial Results
FLORHAM PARK, N.J., April 26, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Zymergen Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
EMERYVILLE, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Zymergen Inc. (“Zymergen”), one of the world’s…
Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB
PITTSBURGH, April 26, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
IRVINE, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
AGTC Announces Departure of Chief Scientific Officer
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…